Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IOBT | Common Stock | Conversion of derivative security | +2.37M | 2.37M | Nov 9, 2021 | See footnote | F1, F2 | |||
transaction | IOBT | Common Stock | Purchase | $9.1M | +650K | +27.48% | $14.00* | 3.02M | Nov 9, 2021 | See footnote | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IOBT | Series C Preferred Stock | Conversion of derivative security | $0 | -188K | -100% | $0.00* | 0 | Nov 9, 2021 | Common Stock | 2.37M | See footnote | F1, F2 |
Id | Content |
---|---|
F1 | Upon the closing of the Issuer's initial public offering, each share of Series C Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Series C Preferred Stock had no expiration date. |
F2 | The securities are held by Vivo Capital Fund IX, L.P. ("Fund IX"). Vivo Capital IX, LLC ("Capital IX") is the general partner of Fund IX. The reporting person is a managing member of Capital IX and may be deemed to share voting and investment power with respect to the shares beneficially owned by Fund IX and disclaims Section 16 beneficial ownership of such securities held by Fund IX, except to the extent of his pecuniary interest therein, if any. |